Tuesday 6 September 2016

Antibodies 2017

About Conference


Conferences Series invites all the participants from all over the world to attend “3rd Antibodies and Bio Therapeutics Congress” during November 02-03, 2017 in Las vegas, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Antibodies-2017 which aims to gather the most elegant societies and industries along with the renowned and honorable persons form top universities across the globe. Antibodies-2017 on behalf of its organizing Committee welcomes all the Immunology researchers, industrialists, young scientists as well as student and corporate delegates to participate and to have a great experience. The theme of the conference of Antibodies is based on “Global Update on Antibodies, Bio Therapeutics: Research, Development and Market”. During Antibodies conferences, the International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Immunology and Microbiology. The conference also welcomes International exhibitions form corporate sectors to showcase the recent advancements in tools and techniques. Conferences Series organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.  

Why to attend???


With members from around the world focused on learning about antibodies and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Antibodies Research are hallmarks of this conference.    

Target Audience


  • Antibodies Students, Scientists
  • Antibodies Researchers
  • Antibodies Faculty
  • Medical Colleges
  • Antibodies Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Manufacturing Medical Devices Companies

Conference Highlights


  • Autoimmune Antibodies
  • Antibody Engineering
  • Antibodies:Infectious Diseases
  • Auto Antibodies
  • Monoclonal Antibody Therapy
  • Antibodies: Medical Applications
  • Immunotherapy and Immune Checkpoints
  • Biosimilar monoclonal antibodies
  • Antibody Drug Therapy
  • Antibodies Immunogenecity
  • Anti-Cancer Antibodies
  • Cancer Immune therapy
  • Antibody Humanization Technologies
  • Biomarkers Development
  • Biotherapeutics: Novel Formulation and Delivery Approaches
  • Biotherapeutics Antibody for the Treatment of Solid Cancers
  • Antibody Fragment Engineering and Applications in Diagnosis and Therapeutics
  • Antibody Conjugate Therapeutics: Challenges and Potential
  • Next-Generation Sequencing (NGS) In Antibody Discovery and Engineering: Overview and Applications
  • Emerging Protein Bio therapeutics
  • Bio therapeutics : Early Analytical Development

Special Issues

    All accepted abstracts will be published in respective Journals.
    Abstracts will be provided with Digital Object Identifier by Cross Ref.
    See more at: http://antibodies.conferenceseries.com/

    3 comments:

    1. Be sure that the meeting room you select have all the facilities you might need for a productive get-together. There's a wide variety of different meeting space San Francisco to choose from - so select the one that fits your occasion.

      ReplyDelete
    2. Awesome blog. I enjoyed reading your articles. This is truly a great read for me. I have bookmarked it and I am looking forward to reading new articles. Keep up the good work! Antibodies

      ReplyDelete
    3. Excellent and very exciting site. Love to watch. Keep Rocking. pentosidine elisa kit mouse

      ReplyDelete